Literature DB >> 12748199

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Aram V Chobanian1, George L Bakris, Henry R Black, William C Cushman, Lee A Green, Joseph L Izzo, Daniel W Jones, Barry J Materson, Suzanne Oparil, Jackson T Wright, Edward J Roccella.   

Abstract

"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure" provides a new guideline for hypertension prevention and management. The following are the key messages(1) In persons older than 50 years, systolic blood pressure (BP) of more than 140 mm Hg is a much more important cardiovascular disease (CVD) risk factor than diastolic BP; (2) The risk of CVD, beginning at 115/75 mm Hg, doubles with each increment of 20/10 mm Hg; individuals who are normotensive at 55 years of age have a 90% lifetime risk for developing hypertension; (3) Individuals with a systolic BP of 120 to 139 mm Hg or a diastolic BP of 80 to 89 mm Hg should be considered as prehypertensive and require health-promoting lifestyle modifications to prevent CVD; (4) Thiazide-type diuretics should be used in drug treatment for most patients with uncomplicated hypertension, either alone or combined with drugs from other classes. Certain high-risk conditions are compelling indications for the initial use of other antihypertensive drug classes (angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, beta-blockers, calcium channel blockers); (5) Most patients with hypertension will require 2 or more antihypertensive medications to achieve goal BP (<140/90 mm Hg, or <130/80 mm Hg for patients with diabetes or chronic kidney disease); (6) If BP is more than 20/10 mm Hg above goal BP, consideration should be given to initiating therapy with 2 agents, 1 of which usually should be a thiazide-type diuretic; and (7) The most effective therapy prescribed by the most careful clinician will control hypertension only if patients are motivated. Motivation improves when patients have positive experiences with and trust in the clinician. Empathy builds trust and is a potent motivator. Finally, in presenting these guidelines, the committee recognizes that the responsible physician's judgment remains paramount.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12748199     DOI: 10.1001/jama.289.19.2560

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  2000 in total

1.  Sumter County on the Move! Evaluation of a Walking Group Intervention to Promote Physical Activity Within Existing Social Networks.

Authors:  Melinda Forthofer; Sara Wilcox; Deborah Kinnard; Brent Hutto; Patricia A Sharpe
Journal:  J Phys Act Health       Date:  2018-12-05

Review 2.  Should two-drug initial therapy for hypertension be recommended for all patients?

Authors:  Jennifer B Cowart; Addison A Taylor
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

3.  Long-term effects of a renin inhibitor versus a thiazide diuretic on arterial stiffness and left ventricular diastolic function in elderly hypertensive patients.

Authors:  Yoshiyuki Okada; Shigeki Shibata; Naoki Fujimoto; Stuart A Best; Benjamin D Levine; Qi Fu
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-07-19       Impact factor: 3.619

4.  Prediction of cardiovascular disease among hematopoietic cell transplantation survivors.

Authors:  Saro H Armenian; Dongyun Yang; Jennifer Berano Teh; Liezl C Atencio; Alicia Gonzales; F Lennie Wong; Wendy M Leisenring; Stephen J Forman; Ryotaro Nakamura; Eric J Chow
Journal:  Blood Adv       Date:  2018-07-24

5.  Disordered eating behaviors and cardiometabolic risk among young adults with overweight or obesity.

Authors:  Jason M Nagata; Andrea K Garber; Jennifer Tabler; Stuart B Murray; Eric Vittinghoff; Kirsten Bibbins-Domingo
Journal:  Int J Eat Disord       Date:  2018-07-21       Impact factor: 4.861

6.  AHA/ACC-defined stage 1 hypertensive adults do not display cutaneous microvascular endothelial dysfunction.

Authors:  Gabrielle A Dillon; Jody L Greaney; Sean Shank; Urs A Leuenberger; Lacy M Alexander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-07-31       Impact factor: 4.733

7.  Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomised controlled trial.

Authors:  Nudrat Noor Qureshi; Juanita Hatcher; Nish Chaturvedi; Tazeen H Jafar
Journal:  BMJ       Date:  2007-11-08

Review 8.  Retinal vascular caliber and the development of hypertension: a meta-analysis of individual participant data.

Authors:  Jie Ding; Khin Lay Wai; Kevin McGeechan; M Kamran Ikram; Ryo Kawasaki; Jing Xie; Ronald Klein; Barbara B K Klein; Mary Frances Cotch; Jie Jin Wang; Paul Mitchell; Jonathan E Shaw; Kayama Takamasa; A Richey Sharrett; Tien Y Wong
Journal:  J Hypertens       Date:  2014-02       Impact factor: 4.844

9.  Physical activity reduces salt sensitivity of blood pressure: the Genetic Epidemiology Network of Salt Sensitivity Study.

Authors:  Casey M Rebholz; Dongfeng Gu; Jing Chen; Jian-Feng Huang; Jie Cao; Ji-Chun Chen; Jianxin Li; Fanghong Lu; Jianjun Mu; Jixiang Ma; Dongsheng Hu; Xu Ji; Lydia A Bazzano; Depei Liu; Jiang He
Journal:  Am J Epidemiol       Date:  2012-10-01       Impact factor: 4.897

10.  Heart failure and cardiac hypertrophy.

Authors:  J Eduardo Rame; Daniel L Dries
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.